IUG vs. BELL, IHC, NCYT, POLX, RUA, SAR, OBD, C4XD, HEMO, and VRCI
Should you be buying Intelligent Ultrasound Group stock or one of its competitors? The main competitors of Intelligent Ultrasound Group include Belluscura (BELL), Inspiration Healthcare Group (IHC), Novacyt (NCYT), Polarean Imaging (POLX), RUA Life Sciences (RUA), Sareum (SAR), Oxford BioDynamics (OBD), C4X Discovery (C4XD), Hemogenyx Pharmaceuticals (HEMO), and Verici Dx (VRCI). These companies are all part of the "medical" sector.
Intelligent Ultrasound Group (LON:IUG) and Belluscura (LON:BELL) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, earnings, profitability, community ranking, valuation, analyst recommendations, media sentiment and institutional ownership.
Intelligent Ultrasound Group and Belluscura both received 0 outperform votes by MarketBeat users.
Belluscura has a net margin of 0.00% compared to Intelligent Ultrasound Group's net margin of -23.11%. Intelligent Ultrasound Group's return on equity of -23.58% beat Belluscura's return on equity.
In the previous week, Intelligent Ultrasound Group's average media sentiment score of 0.00 equaled Belluscura'saverage media sentiment score.
Intelligent Ultrasound Group has higher revenue and earnings than Belluscura. Intelligent Ultrasound Group is trading at a lower price-to-earnings ratio than Belluscura, indicating that it is currently the more affordable of the two stocks.
76.9% of Intelligent Ultrasound Group shares are owned by institutional investors. Comparatively, 15.0% of Belluscura shares are owned by institutional investors. 13.4% of Intelligent Ultrasound Group shares are owned by insiders. Comparatively, 48.1% of Belluscura shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Intelligent Ultrasound Group has a beta of 0.12, meaning that its share price is 88% less volatile than the S&P 500. Comparatively, Belluscura has a beta of 0.86, meaning that its share price is 14% less volatile than the S&P 500.
Summary
Intelligent Ultrasound Group beats Belluscura on 6 of the 11 factors compared between the two stocks.
Get Intelligent Ultrasound Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for IUG and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Intelligent Ultrasound Group Competitors List
Related Companies and Tools
